5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Human pharmacokinetics of T138067, a novel antimicrotubule agent, given as a 3-hour infusion once every 21 to 28 days
    Meeting Abstract

    Berg, W.; Vongphrachanh, P.; Walling, J.; Wright, M.; Ye, Q.; Peterson, K.; Motzer, R.; Thoolen, M.; Timmermans, P.; Soignet, S.; more...
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • A phase I trial of BCL2 antisense drug G3139 (Genta, Inc.) delivered by continuous intravenous infusion alone and in combination with weekly paclitaxel
    Meeting Abstract

    Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Terry, K. L.; DiPaola, R. S.; Rosen, N.; Scher, H. I.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Brachytherapy and teletherapy intensity-modulated treatment planning for prostate using biologic imaging
    Conference Paper

    Amols, H. I.; Happersett, L.; Zaider, M.; Koutcher, J.; Zakian, K.; Hunt, M.; Chui, C.; Dyke, J.; Zelefsky, M.
    Monduzzi Editore (1999)

    Fulltext@MSK | Save
  • Can p53 help select patients with invasive bladder cancer for bladder preservation?
    Journal Article

    Herr, H. W.; Bajorin, D. F.; Scher, H. I.; Cordon-Cardo, C.; Reuter, V. E.
    Journal of Urology (1999)

    Fulltext@MSK | Save
  • Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate-specific antigen working group
    Journal Article

    Bubley, G. J.; Carducci, M.; Dahut, W.; Dawson, N.; Daliani, D.; Eisenberger, M.; Figg, W. D.; Freidlin, B.; Halabi, S.; Hudes, G.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • High-dose chemotherapy as primary treatment for poor-risk germ-cell tumors: The Memorial Sloan-Kettering Experience (1988-1999)
    Journal Article

    Morris, M. J.; Bosl, G. J.
    International Journal of Cancer (1999)

    Fulltext@MSK | Save
  • Management of prostate cancer after prostatectomy: Treating the patient, not the PSA
    Journal Article

    Scher, H. I.
    JAMA - Journal of the American Medical Association (1999)

    Fulltext@MSK | Save
  • Rising PSAs after primary therapy: Active or passive intervention
    Journal Article

    Slovin, S. F.; Scher, H. I.
    Seminars in Urologic Oncology (1999)

    Fulltext@MSK | Save
  • Peptide and carbohydrate vaccines in relapsed prostate cancer: Immunogenicity of synthetic vaccines in man - Clinical trials at Memorial Sloan-Kettering Cancer Center
    Journal Article

    Slovin, S. F.; Scher, H. I.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • The microtubule-stabilizing agents epothilones A and B and their desoxy- derivatives induce mitotic arrest and apoptosis in human prostate cancer cells
    Journal Article

    Sepp-Lorenzino, L.; Balog, A.; Su, D. S.; Meng, D.; Timaul, N.; Scher, H. I.; Danishefsky, S. J.; Rosen, N.
    Prostate Cancer and Prostatic Diseases (1999)

    Fulltext@MSK | Save